Non-Malaysian citizens are subject to 6% SST, to be verified and paid at the counter before screening.
HBcAb-IgM (Hepatitis B Core Antibody IgM) is produced in the early stage of HBV infection. Its presence usually indicates an acute or recent Hepatitis B infection, making it a key marker for disease staging and clinical diagnosis.
A venous blood sample is tested for HBcAb-IgM levels. Results are interpreted with the Hepatitis B panel (HBsAg, HBsAb, HBeAg, HBeAb, HBcAb) and clinical context.
Q1: What does a positive HBcAb-IgM mean?
A: It indicates recent or acute Hepatitis B infection and is a hallmark of acute HBV cases.
Q2: What is the difference between HBcAb-IgM and total HBcAb?
A: IgM suggests recent infection, while total antibody (IgG+IgM) indicates past or chronic infection.
Q3: Does a positive HBcAb-IgM always require treatment?
A: Not always. Management depends on liver function, HBV DNA levels, and symptoms. Some acute cases resolve spontaneously but need follow-up.